Research, introduction, and use: Advancing from Norplant

Contraception

Volumn 58, Issue 6, 1998, Pages 323-334

  Harrison, Polly F ^a   Rosenfield, Allan ^b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NONE   (United States)

Author keywords

Implant contraceptives; Norplant ; Research and development

Indexed keywords

LEVONORGESTREL;

ACCREDITATION; ACNE; AFFECTIVE NEUROSIS; BODY WEIGHT DISORDER; CLINICAL RESEARCH; CONFERENCE PAPER; CONTRACEPTION; DOCTOR PATIENT RELATION; DRUG EFFICACY; DRUG IMPLANT; DRUG SAFETY; DRUG USE; FEMALE; HEADACHE; HEALTH CARE COST; HEALTH CARE DELIVERY; HUMAN; IMMUNOCONTRACEPTION; INFORMED CONSENT; MALE; MARKETING; MEDICAL DECISION MAKING; MENSTRUATION DISORDER; PATIENT COUNSELING; PATIENT SATISFACTION; PELVIS PAIN SYNDROME; POSTMARKETING SURVEILLANCE; PRACTICE GUIDELINE; VAGINA DISCHARGE;

AMERICAS; CONTRACEPTION; CONTRACEPTION RESEARCH; CONTRACEPTIVE AGENTS; CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVE AGENTS, PROGESTIN; CONTRACEPTIVE IMPLANTS; CONTRACEPTIVE METHODS; DEVELOPED COUNTRIES; ECONOMIC FACTORS; FAMILY PLANNING; LEVONORGESTREL; NORTH AMERICA; NORTHERN AMERICA; RESEARCH AND DEVELOPMENT; TECHNOLOGY; UNITED STATES;

CLINICAL TRIALS, PHASE IV; CONTRACEPTION; CONTRACEPTIVE AGENTS, FEMALE; DRUG INDUSTRY; FEMALE; HUMANS; LEVONORGESTREL; PROGESTERONE CONGENERS; TECHNOLOGY, PHARMACEUTICAL; WORLD HEALTH ORGANIZATION;

EID: 0032466346     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(98)00141-3     Document Type: Conference Paper

References (15)

1. 1. Harrison PF, Rosenfield A, eds. Contraceptive Research and Development: Looking to the Future. Washington, DC: Institute of Medicine, 1996.
2. 2. Moore TJ. Prescription for Disaster: The Hidden Dangers in Your Medicine Cabinet. New York: Simon and Schuster, 1998.
3. 3. Ahma J, Chandra A, Mosher W, et al: Fertility, family planning, and women's health: new data from the 1995 National Survey of Family Growth. Vital Health Stat 1997:23(19).
4. 4. Blumenthal PD, Gaffikin L, Affandi B, et al. Training for Norplant implant removal: assessment of learning curves and competency. Obstet Gynecol 1997;89:174-8.
5. 5. Davidson AR, Kalmuss D. Topics for our times: Norplant coercion - an overstated threat. Am J Pub Health 1997;87:550-1.
6. 6. Can contraception reduce the underclass? (editorial). Philadelphia Inquirer 1990;Dec 12:A18.
7. 7. Samuels SE, Smith MD (eds). Dimensions of New Contraceptives: Norplant and Poor Women. Menlo Park, CA: Henry J. Kaiser Family Foundation, 1992.
8. 8. Moskowitz EH, Jennings B, Callahan D. Long-acting contraceptives: ethical guidance for policymakers and health care providers. Hastings Center Report 1995;25 (suppl).
9. 9. Walker KM. Judicial control of reproductive freedom: the use of Norplant as a condition of probation. Iowa Law Review 1993;78:779-812.
10. 10. Roberts DE. Punishing drug addicts who have babies: women of color, equality, and the right of privacy. Harvard Law Review 1991;104:1419, 1932 n. 60.
11. 11. Chang D. Getting United States Vaccines Abroad Through Muli-tiered Pricing: An Analytic Framework to Explore the Possibility of United States Policy Adoption. Paper prepared for John F. Kennedy School of Government, Harvard University, and WHO Children's Vaccine Initiative Secretariat, Geneva, 7 April 1998.
12. 12. Harrison PF, Lederberg J, eds. Orphans and Incentives: Developing Technologies to Address Emerging Infections. Washington, DC: National Academy Press, 1997.
13. 13. Roan S. The chill in birth control research. Los Angeles Times 1998;23 March.
14. 14. Mastroianni L Jr, Donaldson PJ, Kane TT (eds). Developing New Contraceptives: Obstacles and Opportunities. Washington DC: National Academy Press, 1990.
15. 15. Norsigian J. Contraception blues. In These Times 1997;17 February: 17-9.